Atosiban ( DrugBank: Atosiban )
1 disease
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 118 | 脊髄髄膜瘤 | 1 |
118. 脊髄髄膜瘤
臨床試験数 : 10 / 薬物数 : 18 - (DrugBank : 7) / 標的遺伝子数 : 8 - 標的パスウェイ数 : 12
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04468568 (ClinicalTrials.gov) | January 8, 2017 | 1/3/2020 | In Utero Repair of Myelomeningocele: Atosiban Versus Terbutaline | Assessment of Maternal Blood Gas Changes When Using Atosiban and Terbutaline as Tocolytic Agents, During in Utero Repair of Myelomeningocele | Myelomeningocele;Terbutaline Adverse Reaction;Pregnancy; Malformation Central Nervous System | Drug: Atosiban;Drug: Terbutaline | University of Sao Paulo General Hospital | NULL | Recruiting | 18 Years | 40 Years | Female | 28 | N/A | Brazil |